Breakthrough sleep apnea medication AD109 shows promising results in phase 3 trials, potentially helping 30 million Americans with the condition.

Sleep apnea affects as many as 80 million in the U.S. Now Apnimed, the $400 million company behind the first ever pill to treat it, is preparing to file for FDA approval.

In Manhattan, exhaustion is often treated as part of the lifestyle. Long workdays, late nights, early mornings, and packed ...

Sleep apnea is a debilitating disease that many sufferers don’t even realize they have. Those afflicted with the condition ...

Nearly five years after the Philips Respironics recall reshaped the CPAP market, respondents to a recent HME Newspoll say ...

A new pill for sleep apnea could offer hope for those struggling with CPAP machines, according to leading researchers.

It could be a game-changer for the millions of Americans who suffer from sleep apnea. A new first-of-its-kind pill could ...

Sleep apnea, a condition affecting more than 12 million Americans, can lead to a host of health problems including heart disease. But, a new treatment containing ingredients derived from cannabis is ...

There's no doubt we need better treatments for sleep apnea. This implant is kind of like a pacemaker. It's only for one type of sleep apnea but the goal is the same-to make sure you keep breathing and ...

NEW BERN, N.C. (WNCT) — A medical team with the CarolinaEast Health System are offering a new solution for those who struggle with a CPAP machine. Medical personnel with the Ear, Nose and Throat ...